Medisse BV, founded in 2006 as a spin-off of University Twente, is a leading innovator and developer of synthetic resorbable soft tissue implants. The Company’s first product, the FlexiSurge® Adhesion Barrier, is currently tested in a clinical study to obtain the clinical data needed for CE marking early in 2015.
Using PTMC technology, Medisse is exploring a wide range of resorbable implants for a large number of surgical indications. Below is our current product development pipeline, which is only a small selection of conceivable devices:
FlexiSurge® Adhesion Barrier
Composite Hernia Mesh